Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10,266 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Therapeutic effectiveness of anlotinib combined with etoposide in extensive-stage small-cell lung cancer: a single-arm, phase II trial.
Wu Y, Zhou X, Zhao W, Wang Q, Han Z, Wang L, Zhou W, Zhou T, Song H, Chen Y, Yang K, Shi L, Pan B, Guo R, Zhou G, Jiang F, Feng J, Shen B. Wu Y, et al. Among authors: zhou x, zhou t, zhou w, zhou g. Invest New Drugs. 2023 Dec;41(6):825-833. doi: 10.1007/s10637-023-01398-9. Epub 2023 Oct 14. Invest New Drugs. 2023. PMID: 37837490 Free PMC article. Clinical Trial.
Plasma membrane abundance dictates phagocytic capacity and functional cross-talk in myeloid cells.
Winer BY, Settle AH, Yakimov AM, Jeronimo C, Lazarov T, Tipping M, Saoi M, Sawh A, Sepp AL, Galiano M, Perry JSA, Wong YY, Geissmann F, Cross J, Zhou T, Kam LC, Pasolli HA, Hohl T, Cyster JG, Weiner OD, Huse M. Winer BY, et al. Among authors: zhou t. Sci Immunol. 2024 Jun 7;9(96):eadl2388. doi: 10.1126/sciimmunol.adl2388. Epub 2024 Jun 7. Sci Immunol. 2024. PMID: 38848343
10,266 results
You have reached the last available page of results. Please see the User Guide for more information.